Reply to Achieng and Riedel
J Infect Dis
.
2019 Jan 1;219(1):167-169.
doi: 10.1093/infdis/jiy437.
Authors
Hanh Thi Pham
1
2
,
Mark E Goring
1
3
,
Thibault Mesplède
1
2
3
4
Affiliations
1
McGill AIDS Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
2
Department of Microbiology and Immunology, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
3
Division of Experimental Medicine, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
4
Division of Infectious Diseases, Jewish General Hospital, Faculty of Medicine, McGill University, Montréal, Québec, Canada.
PMID:
30165488
DOI:
10.1093/infdis/jiy437
No abstract available
Publication types
Letter
Comment
MeSH terms
Heterocyclic Compounds, 3-Ring*
Integrases*
Oxazines
Piperazines
Pyridones
Serologic Tests
Substances
Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
dolutegravir
Integrases